MDPI and ACS Style
Triulzi, T.; Regondi, V.; Venturelli, E.; Gasparini, P.; Ghirelli, C.; Groppelli, J.; Di Modica, M.; Bianchi, F.; De Cecco, L.; Sfondrini, L.;
et al. HER2 mRNA Levels, Estrogen Receptor Activity and Susceptibility to Trastuzumab in Primary Breast Cancer. Cancers 2022, 14, 5650.
https://doi.org/10.3390/cancers14225650
AMA Style
Triulzi T, Regondi V, Venturelli E, Gasparini P, Ghirelli C, Groppelli J, Di Modica M, Bianchi F, De Cecco L, Sfondrini L,
et al. HER2 mRNA Levels, Estrogen Receptor Activity and Susceptibility to Trastuzumab in Primary Breast Cancer. Cancers. 2022; 14(22):5650.
https://doi.org/10.3390/cancers14225650
Chicago/Turabian Style
Triulzi, Tiziana, Viola Regondi, Elisabetta Venturelli, Patrizia Gasparini, Cristina Ghirelli, Jessica Groppelli, Martina Di Modica, Francesca Bianchi, Loris De Cecco, Lucia Sfondrini,
and et al. 2022. "HER2 mRNA Levels, Estrogen Receptor Activity and Susceptibility to Trastuzumab in Primary Breast Cancer" Cancers 14, no. 22: 5650.
https://doi.org/10.3390/cancers14225650